Completed Engineering Cancer

Centre for Doctoral Training in Healthcare Innovation

In plain English

AI plain-English summary

Oxford is training a new generation of biomedical engineers who can take a lab-tested device or algorithm and run the first clinical tests on real patients. Most engineering PhDs focus on technical depth but leave graduates unprepared for the messy reality of clinical validation—designing tests under hospital constraints, navigating ethics approvals, assessing commercial potential, and collaborating with clinicians who have different priorities. This Centre for Doctoral Training fills that gap by embedding hospital internships, industry placements, and modules on clinical trials and entrepreneurship into a four-year programme. If it succeeds, the Centre will produce researchers who can move medical technologies from the bench to the bedside faster and more reliably. That could mean quicker development of new cancer therapies, personalised treatment models based on patient-specific imaging data, and information-driven healthcare tools that improve diagnosis and monitoring. The three research themes—cancer therapeutics, modelling for personalised healthcare, and information-driven healthcare—are tied to new Oxford clinical facilities and recent EPSRC digital economy bids, giving students direct access to real clinical problems and industry partners.

View original technical description
This Doctoral Training Centre (DTC) bid concerns developing the next generation of biomedical engineering researchers who, to be competitive in this fast-moving global area of engineering, need not only to be well-equipped with knowledge of modern biomedical engineering (BME) principles and techniques, but also well-versed in translational research skills (principles of clinical trials and commercialization of research). Modern BME research spans a range of technical areas, from hardware devices, to software systems, to artificial organs, biomaterials and drug delivery. It requires engineering researchers to understand biology/physiology relevant to their area, and increasingly multiple engineering disciplines that are only touched on in UK undergraduate education (e.g. modelling and imaging, sensor technology and biomaterials). This new DTC will attract and capture more UK engineering talent to this area and specifically to work at the translational interface. The translational interface takes laboratory-tested devices and methodology through the first steps of clinical validation. This does not just mean running a device or algorithm on a few clinical data sets. It requires close collaboration with clinicians, and deals with understanding how to design tests for a device/system in a clinical scenario and subject to constraints imposed by clinical practice; evaluating the technical and clinical strengths/weaknesses of a technology with the most appropriate statistical methodology; and via this, identifying new academic research questions that can be addressed in the development of the next generation of the technology. It also requires researchers to be aware of ethical issues (research involves patients), and commercialization issues (technology may be patentable and/or start the medical devices approval process). Research at the translational interface is thus fundamental to the advancement of the biomedical engineering field. The skills-base required for this would be most effectively obtained through formal training at the postgraduate level to prepare students for careers in industry or academia. At the University of Oxford we have established a critical mass of biomedical engineering research at the translational interface in the new Institute of Biomedical Engineering (IBME) that would make this training most effectively achieved by establishing a DTC Programme.Three research themes have been identified for the DTC which are closely related to new biomedical research initiatives in the University of Oxford: cancer therapeutics (linked to the new Institute of Cancer Medicine and Oxford Cancer Hospital); modelling for personalised healthcare (linked to the Oxford Acute Vascular Imaging Centre), and information-driven healthcare (linked to recent successful bids from the recent EPSRC Digital Economy call).Postgraduate students on the DTC will participate in an intensive training programme in their first year, including a hospitial internship, modules on BME foundations (modelling, signals/systems, experimental methods), each of the 3 research themes, commercialization and entrepreneurship, and statistical methods and clinical trials. Students will also undertake 2 short projects, one of which must take place in industry or a hospital. One of the projects will become their doctoral research project. In yrs 2-4 the main focus is the research project, with an option to spend time visiting an international laboratory. Throughout there will be a programme of research skills training, and opportunities to engage with industry.The proposal has strong support from our clinical collaborators and industry players both large and small.

View the original record at the funder ↗

Researchers

Alison Noble (Principal Investigator)Peter Dobson (Co-Investigator)Rebecca Lingwood (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

EPSRC Centre for Doctoral Training in Medical Imaging
Industrial Doctorate Centre: Systems Approaches to Biomedical Science
EPSRC and MRC Centre for Doctoral Training in Biomedical Imaging
EPSRC Centre for Doctoral Training in Advanced Engineering for Personalised Surgery & Intervention
EPSRC and MRC Centre for Doctoral Training in Optical Medical Imaging - Training the next generation of scientific entrepreneurs in healthcare tech.

Original classification

Training Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.